Inotuzumab ozogamicin in B-cell precursor acute lymphoblastic leukemia: efficacy, toxicity, and practical considerations.
BCP-ALL
CD22
acute lymphoblastic leukemia
antibody drug conjugate
inotuzumab ozogamicin
relapse/refractory
sinusoidal obstruction syndrome
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
09
06
2023
accepted:
20
07
2023
medline:
22
8
2023
pubmed:
21
8
2023
entrez:
21
8
2023
Statut:
epublish
Résumé
Inotuzumab ozogamicin (InO) is an antibody drug conjugate composed of a humanized monoclonal antibody targeting the cell surface receptor CD22 coupled to a cytotoxic calicheamicin payload
Identifiants
pubmed: 37600823
doi: 10.3389/fimmu.2023.1237738
pmc: PMC10435844
doi:
Substances chimiques
Inotuzumab Ozogamicin
P93RUU11P7
Antibodies, Monoclonal, Humanized
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1237738Informations de copyright
Copyright © 2023 Rubinstein and O’Brien.
Déclaration de conflit d'intérêts
MO’B previously received research support from Pfizer Inc. through a Pfizer ASPIRE Hematology/Oncology Grant which is completed. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nat Med. 2021 Oct;27(10):1797-1805
pubmed: 34642489
Leukemia. 2022 Jun;36(6):1516-1524
pubmed: 35468945
Hepatology. 2019 Feb;69(2):831-844
pubmed: 30120894
J Clin Oncol. 2022 Mar 20;40(9):932-944
pubmed: 34767461
Front Immunol. 2020 Apr 03;11:489
pubmed: 32318059
Lancet Haematol. 2017 Aug;4(8):e387-e398
pubmed: 28687420
Blood. 2022 Aug 4;140(5):451-463
pubmed: 35605184
Blood. 2021 Mar 25;137(12):1582-1590
pubmed: 33067614
Blood. 2014 Jan 2;123(1):70-7
pubmed: 24222333
Am J Hematol. 2019 Apr;94(4):408-416
pubmed: 30623490
Leuk Res. 2007 May;31(5):599-604
pubmed: 16959316
N Engl J Med. 2018 Feb 1;378(5):439-448
pubmed: 29385370
Cytometry B Clin Cytom. 2011 Mar;80(2):83-90
pubmed: 20872890
Cancer. 2013 Aug 1;119(15):2728-36
pubmed: 23633004
Blood. 2018 Aug 23;132(8):815-824
pubmed: 29997224
Bone Marrow Transplant. 2018 Apr;53(4):449-456
pubmed: 29330398
J Clin Oncol. 2022 Mar 20;40(9):956-967
pubmed: 35007127
Blood Adv. 2023 Jan 24;7(2):251-255
pubmed: 35500285
Lancet Haematol. 2023 May;10(5):e333-e345
pubmed: 37001534
Biol Blood Marrow Transplant. 2016 Jul;22(7):1306-1312
pubmed: 27108694
Cancers (Basel). 2023 Mar 19;15(6):
pubmed: 36980732
Lancet Oncol. 2018 Feb;19(2):240-248
pubmed: 29352703
Cancer. 2022 Feb 01;128(3):529-535
pubmed: 34633671
Biol Blood Marrow Transplant. 2013 Mar;19(3):500-3
pubmed: 23211838
Blood. 2010 Apr 8;115(14):2740-8
pubmed: 20124218
Blood Adv. 2017 Jun 27;1(15):1167-1180
pubmed: 29296758
Blood Cancer Discov. 2022 Mar 01;3(2):103-115
pubmed: 35015683
Leuk Res. 2020 Jan;88:106283
pubmed: 31790983
Leukemia. 2022 Mar;36(3):648-655
pubmed: 34725453
Cancer. 2018 Mar 15;124(6):1150-1159
pubmed: 29266189
J Clin Oncol. 2020 Feb 20;38(6):602-612
pubmed: 31825704
J Clin Oncol. 2022 Mar 20;40(9):945-955
pubmed: 34882493
Am J Hematol. 2021 Aug 1;96(8):1000-1007
pubmed: 33991360
AAPS J. 2016 Sep;18(5):1101-1116
pubmed: 27198897
J Oncol Pharm Pract. 2023 Jun;29(4):840-845
pubmed: 35293248
Cancer Res. 2008 Aug 1;68(15):6300-5
pubmed: 18676854
Biol Blood Marrow Transplant. 2020 Nov;26(11):e280-e285
pubmed: 32755637
J Pharmacokinet Pharmacodyn. 2019 Jun;46(3):211-222
pubmed: 30859374
Int J Mol Sci. 2021 Jun 16;22(12):
pubmed: 34208575
Clin Cancer Res. 2017 Apr 1;23(7):1760-1770
pubmed: 27683177
Pediatr Blood Cancer. 2021 Aug;68(8):e29067
pubmed: 33871892
Br J Haematol. 2021 Jun;193(6):1172-1177
pubmed: 33529389
Pediatr Blood Cancer. 2015 Jun;62(6):964-9
pubmed: 25728039
Blood. 2023 Mar 23;141(12):1379-1388
pubmed: 36548957
J Clin Oncol. 2023 May 31;:JCO2202200
pubmed: 37257143
N Engl J Med. 2016 Aug 25;375(8):740-53
pubmed: 27292104
Lancet Oncol. 2012 Sep;13(9):936-45
pubmed: 22898679
JAMA. 2021 Mar 2;325(9):833-842
pubmed: 33651090
Blood. 2021 May 13;137(19):2657-2661
pubmed: 33512436
Nat Med. 2018 Jan;24(1):20-28
pubmed: 29155426
Blood. 2020 Oct 15;136(16):1803-1812
pubmed: 32589723
Clin Transl Sci. 2021 Jan;14(1):184-193
pubmed: 32812370
Leukemia. 2007 Nov;21(11):2240-5
pubmed: 17657218
Biol Blood Marrow Transplant. 2019 Sep;25(9):1720-1729
pubmed: 31039409
Lancet Haematol. 2023 Jun;10(6):e433-e444
pubmed: 37187201
Pediatr Blood Cancer. 2014 Feb;61(2):369-72
pubmed: 24000241
Cancers (Basel). 2020 Jan 28;12(2):
pubmed: 32012891
Leukemia. 2019 Apr;33(4):884-892
pubmed: 30267011
Cancer. 2023 May 1;129(9):1384-1393
pubmed: 36829303
Am J Hematol. 2015 Mar;90(3):193-6
pubmed: 25407953
Blood. 2006 Nov 15;108(10):3302-4
pubmed: 16896151
Clin Lymphoma Myeloma Leuk. 2013 Jun;13(3):296-301
pubmed: 23313065
J Immunol. 1995 May 1;154(9):4466-75
pubmed: 7722303
J Clin Oncol. 2020 Aug 10;38(23):2628-2638
pubmed: 32496902
Nat Med. 2021 May;27(5):842-850
pubmed: 33888899
Blood. 2003 Sep 1;102(5):1578-82
pubmed: 12738663
Lancet Haematol. 2020 Jan;7(1):e61-e72
pubmed: 31818728
Immunol Rev. 2009 Jul;230(1):128-43
pubmed: 19594633
Leukemia. 2022 May;36(5):1215-1226
pubmed: 35368047
Cancer. 2018 Oct 15;124(20):4044-4055
pubmed: 30307611
Blood Adv. 2022 Jan 25;6(2):600-610
pubmed: 34794180
Leukemia. 2023 Jan;37(1):53-60
pubmed: 36310183
Haematologica. 2022 Sep 01;107(9):2064-2071
pubmed: 35142153
Br J Haematol. 2020 Sep;190(6):822-836
pubmed: 32133623
J Clin Oncol. 2020 Jun 10;38(17):1938-1950
pubmed: 32286905
N Engl J Med. 2016 Sep 15;375(11):1044-53
pubmed: 27626518
Br J Haematol. 2020 Oct;191(1):123-126
pubmed: 32648276
Front Oncol. 2022 Jun 15;12:933317
pubmed: 35785209
Lancet Oncol. 2012 Apr;13(4):403-11
pubmed: 22357140
Leukemia. 2012 Feb;26(2):255-64
pubmed: 21869836
Clin Cancer Res. 2021 May 15;27(10):2742-2754
pubmed: 33602684
J Clin Oncol. 2010 Apr 20;28(12):2085-93
pubmed: 20308665
Cancer. 2019 Jul 15;125(14):2474-2487
pubmed: 30920645
J Clin Invest. 2019 Mar 12;129(5):2123-2132
pubmed: 30860496
Cancer. 2021 Apr 1;127(7):1039-1048
pubmed: 33259056
Blood. 2004 Mar 1;103(5):1807-14
pubmed: 14615373
Cancer. 2021 Mar 15;127(6):905-913
pubmed: 33231879
JAMA Oncol. 2018 Feb 01;4(2):230-234
pubmed: 28859185
Blood Adv. 2022 Apr 12;6(7):2167-2182
pubmed: 34920453
Hematol Oncol. 2022 Oct;40(4):734-742
pubmed: 35618655
Leuk Lymphoma. 2020 Aug;61(8):2012-2015
pubmed: 32378440